{"nctId":"NCT00836810","briefTitle":"Timed Release Tablet Prednisone in Polymyalgia Rheumatica","startDateStruct":{"date":"2009-10"},"conditions":["Polymyalgia Rheumatica"],"count":12,"armGroups":[{"label":"Timed Release Tablet Prednisone","type":"EXPERIMENTAL","interventionNames":["Drug: Timed Release Tablet Prednisone"]},{"label":"Standard Prednisolone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Prednisolone"]}],"interventions":[{"name":"Timed Release Tablet Prednisone","otherNames":["Lodotra"]},{"name":"Prednisolone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of PMR by standard criteria. The Bird criteria will be used. 3 or more features are required to make the diagnosis.\n\n  * Bilateral shoulder pain/stiffness\n  * Duration of symptoms \\<2/52\n  * Initial ESR \\>40 mm/h\n  * Stiffness \\>1 h\n  * Age \\>65 years\n  * Depression and/or weight loss\n  * Bilateral upper arm tenderness\n* Are over 50 but less than 85 years old.\n* No or stable NSAID or analgesic therapy for at least 7 days.\n* Currently active disease defined by a CRP at least 10mg/L, ESR at least 29mm in one hour or PV \\>1.72\n\nExclusion Criteria:\n\n* Currently on oral glucocorticoid treatment or taken within 2 months\n* Parenteral glucocorticoid treatment with the last 2 months\n* Pregnancy and lactation\n* Inflammatory diseases such as inflammatory bowel disease, colitis, asthma\n* Co-existent giant cell arteritis\n* Other auto-immune diseases\n* Cancer\n* Infections, treatment with antibiotics within the past 6 weeks\n* Significant renal disease (creatinine \\>150 Î¼mol/L)\n* Significant hepatic impairment\n* Participation in a clinical trial within the past 30 days\n* Working shift employee\n* Jet lag","healthyVolunteers":false,"sex":"ALL","minimumAge":"50 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Peak Serum IL-6 Concentration","description":"Pre-treatment (Night A) peak minus post-treatment (Night B) peak. Peaks defined as the highest value for each patient from measures at 0, 1.5, 3, 4.5, 5.5, 6.5, 7.5, 8.5, 9.5, 10.5, 11.5, 12.5, 13.5, 14.5, 15.5, 17, 19, 20.5, 22, and 24 hours after 16.30 on day before treatment (Night A) and last day of treatment (Night B) and the peak identified for each one.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.5","spread":"8.3"},{"groupId":"OG001","value":"29.3","spread":"15.1"}]}]}]},{"type":"PRIMARY","title":"Change in Area Under the Curve (AUC) of Plasma IL-6","description":"Pre-treatment (Night A) AUC minus post-treatment (Night B) AUC. AUC calculated from measures at 0, 1.5, 3, 4.5, 5.5, 6.5, 7.5, 8.5, 9.5, 10.5, 11.5, 12.5, 13.5, 14.5, 15.5, 17, 19, 20.5, 22, and 24 hours after 16.30 on day before treatment (Night A) and last day of treatment (Night B).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"113.5","spread":"77.7"},{"groupId":"OG001","value":"97.9","spread":"84.3"}]}]}]},{"type":"SECONDARY","title":"Percentage Change in Morning Stiffness","description":"How long was your morning stiffness today? Pre-treatment (Night A) value minus post-treatment (Night B) value divided by pre-treatment value.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":"38.7"},{"groupId":"OG001","value":"115.0","spread":"55.0"}]}]}]},{"type":"SECONDARY","title":"Pain (Severity)","description":"100mm visual analogue scale. Question: How much pain have you had in the last 24 hours? Anchors: No pain; Severe pain. Min score 0, Max score 100. Higher value is worse outcome.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.5","spread":"25.3"},{"groupId":"OG001","value":"19.5","spread":"13.1"}]}]}]},{"type":"SECONDARY","title":"Patient's Opinion of Condition","description":"100mm visual analogue scale. Question: Considering all the ways your pain and/or stiffness affect(s) you, please mark on the line how well you are doing. Anchors: Very well; Very badly. Min 0 Max 100 (poor outcome).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.8","spread":"20.6"},{"groupId":"OG001","value":"26.0","spread":"17.6"}]}]}]},{"type":"SECONDARY","title":"Clinician's Opinion of Disease Activity.","description":"100mm visual analogue scale. Question: Clinician's opinion of disease activity. Anchors: None; Severe Min 0 Max 100 (worse)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.0","spread":"18.1"},{"groupId":"OG001","value":"20.3","spread":"9.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":4},"commonTop":[]}}}